After Endo’s Plunge, These Stocks Could Be Next
May 06, 2016 at 13:39 PM EDT
Shares of Endo International ( ENDP ) have tumbled 40% today after it said profits would fall well short of analyst expectations thanks, in part, to plunging generic drug prices. Leerink's Jason Gerberry and team look for specialty pharmaceutical companies that have similar business models--and find Akorn ( AKRX ), Perrigo ( PRGO ), and Teva Pharmaceutical Industries ( TEVA ). They explain:
